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doi:10.1016/j.ejvs.2011.08.015Abstract Objective: The aim of the study is to summarise our experience of endovascular
stent grafting for Stanford type A aortic dissection.
Design: Retrospective analysis at single centre.
Methods: From January 2001 to January 2009, we treated 45 cases of Stanford type A aortic
dissection with endovascular stent grafting. The entry tear was located at the ascending aorta
in 10 cases (DeBakey type I), the aortic arch in 14 cases and the distal aortic arch or proximal
descending aorta in 21 cases in which the ascending aorta was also involved by the dissection.
Results: The surgical success rate was 97.8% (44/45) and 30-day mortality rate was 6.7% (3/
45). Type I endoleaks occurred in 10 cases: one patient died intra-operatively, four were
successfully treated with ballooning, four were sealed with aortic cuffs and one case caused
by left subclavian artery (LSA) reflux was sealed with an occluder. Average follow-up time
was 35.5  5.4 months. Up to the most recent review or death, 32 patients had complete
thrombosis and 10 had partial thrombosis inside the false lumen. Two deaths occurred after
30-days postoperatively.
Conclusion: Endovascular stent-graft treatment is a minimally invasive and effective method
to treat Stanford type A aortic dissection.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.According to the Stanford classification, all lesions dissec-
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Although traditional open aortic replacement is an effec-
tive treatment for Stanford type A aortic dissections (ADs),35886.
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788 C. Ye et al.it is associated with a mortality rate ranging from 15% to
30%.3e6
Though an endovascular approach has been proven
useful for the management of abdominal aortic and thoracic
aortic aneurysms and the treatment of Stanford type B dis-
sections,7e10 it is only in the past decade that the endo-
vascular approach has been examined for the management
of type A dissections.11e17
Since 2001, we have been treating Stanford type A ADs
with endovascular stent-graft implantation. The purpose of
this retrospective study is to present the results of our
cumulative experience of the endovascular treatment of
Stanford type A ADs.
Patients and Methods
Clinical data
From January 2001 to January 2009, 166 cases of Stanford
type A ADs were treated at our hospital. Of these, 79
patients received open surgery, 42 patients declined
surgical treatment and 45 were managed by endovascular
stent grafting and included in this analysis. If the areas of
the aortic valve and coronary artery ostia were not affected
and the distance between the entry tear and the coronary
ostia was >2.5 cm, patients were offered the option of
endovascular repair. Patients were not offered endovas-
cular management if the aforementioned criteria were not
met, the dissection was trauma induced, or if the whole AO
was affected. After discussion of the surgical options, the
patient or their relatives made the decision as to the type
of surgery.
There were 41 males and four females with a median age
of 51 years (range, 38e79 years) included in this analysis.
There were 30 cases of acute AD (14 days) and 15 cases of
chronic AD (>14 days). Computed tomographic angiography
(CTA), magnetic resonance angiography (MRA) and aortic
angiography were performed in all cases to determine the
intimal entry tear location and the extent of the dissection.
Preoperative echocardiography was performed to detect
aortic valve insufficiency or regurgitation, coronary artery
dissection and to measure the distance from the entry tear
to the coronary artery ostium. Patient clinical data are
presented in Table 1. Patients were categorised into three
groups: group A (n Z 10), DeBakey type I AD; group B
(nZ 14), entry tear located at the aortic arch; and group C
(n Z 21) entry tear at the distal aortic arch or descending
aorta in which the ascending aorta was also involved by the
dissection. All patients provided informed consent for the
procedures and approval was obtained from the Institu-
tional Review Board of our hospital.
Endovascular interventions
All patients underwent surgery under general anaesthesia
without cardiopulmonary bypass. The stent grafts used
included the Medtronic Talent (Medtronic Inc., Minneap-
olis, MN, USA), Cook Zenith (Cook Medical, Inc., Bloo-
mington, IN, USA), Ancure II (XianJian Science and
Technology Company, China) and Aegis (MicroPort Medical
Co., Ltd, Shanghai, China). Stent diameters ranged from30 to42mmand the length of the covered stent ranged from 100 to
150 mm. Aortic cuff diameters ranged from 32 to 42 mm and
the length of the covered stent ranged from 50 to 80 mm.
Stent grafts were oversized by 5e10%. The grafts for trans-
position of arch vessels were expanded polytetrafluro-
ethylene (ePTFE) Gore-Tex (W.L. Gore Associates Inc.,
Flagstaff, AZ, USA).
If the entry tear was located in the proximal descending
aorta, the stent was placed near the ostium of the left
subclavian artery (LSA) and if an endoleak occurred, the
stent was expanded by balloon so that it was tightly
adhered to the vessel wall. If the endoleak was caused by
stent mobilisation or angulation, an aortic extending cuff
was implanted. If the endoleak was caused by reflux from
the LSA, an occluder was implanted through the left
brachial artery to close the orifice of the LSA. In all cases,
systolic blood pressure was controlled to approximately
90 mmHg during deployment of the prostheses. We did not
use rapid pacing, cardiac arrest or over pacing. Represen-
tative images of group A, B and C patients are presented in
Figs. 1e3. Patients were followed with CTA the first, sixth,
and 12th month postoperatively, then yearly.
Group A
In nine patients aortic cuff stents ranging from 60 to 80 mm
were used, and in one patient a 10-cm covered stent was
used. In two patients, stents were introduced through the
left common carotid artery (LCCA) and LSAeLCCA bypass
was constructed prior to the stent implantation. In the
other eight patients, stents were introduced through the
right common femoral artery (RCFA). In two of these
patients, the entry tears were close to the innominate
artery such that sealing of entry tears with stents might
have led to closure of the innominate artery, and possibly
LCCA. Therefore, LSAeLCCAeright common carotid artery
(RCCA) bypasses were performed. In all cases, the stent
graft was placed under low blood pressure, placement was
confirmed radiographically and was adjusted, if required,
and then was released.
Group B
All patients were treated with supra-aortic transposition
(Table 1) and one- or two-stage endovascular stent graft-
ing. After the transposition procedure, stent grafts were
implanted through the RCFA into the aortic arch in one or
two stages to close the entry tears together with the ostia
of supra-aortic great vessels. In two cases, the entry tears
were close to the LSA and because the right vertebral
artery (RVA) was not the dominant artery, revascularisation
of the LSA was performed. In these patients, the ascending
aorta was not affected since the tear was primarily on the
aortic arch and thus had a normal length of ascending aorta
for debranching.
Group C
The entry tear was located at the distal aortic arch in
nine patients and at the descending aorta in 12 patients. A
one-stage procedure was performed in all patients, and
17 were treated with endovascular stent grafting only. The
LSAs in 10 patients were covered simultaneously, in whom
four were shown to have RVA occlusion or stenosis >70%
by preoperative arteriography. LSAeLCCA bypass was
Table 1 Patient characteristics (N Z 45).
Group A:
Entry Tear at
Ascending Aorta
Group B:
Entry Tear at
Aortic Arch
Group C:
Entry Tear at Descending
Aorta or Distal Aortic Arch
N 10 14 21
Gender
Male 9 13 19
Female 1 1 2
Age (y) 51 (41e71) 53 (38e75) 55 (41e79)
Dissection
Acute 6 9 15
Chronic 4 5 6
Duration from onset to operation (d) 3e73 e e
Acute chest pain All e e
Sudden chest pain e All All
Upper back pain All All 16
Hypertension All All 17
History of connective tissue disease 0 1 (Marfan syndrome) 0
Distance to coronary artery ostium (cm) 2.5e6 e e
Distance to right innominate artery (cm) 0.5e4 e e
Entry tear between BA and LCCA e 4 e
Entry tear between LCCA and LSA e 10 e
Entry tear at distal aortic arch e e 9
Entry tear at descending aorta e e 12
Diameter of intimal tear (cm) 0.8e2.0 0.8e1.6 0.9e1.5
Diameter of dissection (cm) 4.5e7.5 5.5e10.3 6e11.2
Left common carotid artery path 2 e e
Right femoral artery path 2 e e
Endovascular stent grafting and supra-aortic
great vessel transposition
2 14 4
AO-LCCA and RCCA e 1 e
AO-LSA and LCCA e 3 e
LCCA-RCCA e 8
LCCA-LSA e 2 4
RCFA path e All e
One-stage procedure 1 7 All
Two-stage procedure 1 7 e
Endovascular stent grafting only 8 e 17
Acute dissection defined as 14 days, chronic dissection defined as >14 days.
Data are presented as number (range).
AO, ascending aorta; BA, brancliocephalic artery; LCCA, left common carotid artery; LSA, left subclavian artery; RCCA, right common
carotid artery; RFCA, right common femoral artery.
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patients did not receive LSA revascularisation because
angiography indicated good blood supply of the RVA and
Circle of Willis.Results
The endovascular procedure was successfully performed in
44 of the 45 patients (97.8%). One intra-operative death
occurred in group B. In this case, a bypass graft was placed
between the LCCA and RCCA, and a stent graft was
successfully deployed to seal the tear. A delayed type I
endoleak was found, and balloon angioplasty was per-
formed. During the procedure, the patient experienced
cardiopulmonary arrest and died. In one case in group C,the entry tear was located at the descending aorta, but the
dissection involved the ascending aorta. Three hours after
successful stent-graft implantation, the patient experi-
enced a myocardial infarction and died. In group A, one
patient died from gastrointestinal haemorrhage 25 days
postoperatively. Thus, the 30-day postoperative mortality
rate was 6.7% (3/45).
The mean follow-up of the 42 patients who survived
beyond 30 days was 35.5  5.4 months (range, 4e112
months). Therewere twodeaths during the follow-upperiod;
thus, the total mortality rate was 11.1% (5/45). One patient
in group B with Marfan syndrome died 2 months post-
operatively. The patient’s family did not allow an autopsy;
thus the cause of death is unknown. A patientwith a DeBakey
type I dissection was discharged and died from pneumonia
and acute left ventricular failure 10months postoperatively.
Figure 1 Group A. A) Preoperative DSA showed an aortic dissection with tear 1.5 cm from the right innominate artery, 5 cm from
the ostium of coronary artery, and B) 2.0 cm in diameter. C) Endoleak remained after the first stent was implanted through LCCA.
D) A second stent was implanted to close the tear and the leakage stopped.
Figure 2 Group B. A) Tear on aortic arch between LCCA and LSA. Another tear was located below the level of the renal artery. B)
Postoperative DSA showed good circulation in the carotid artery bypass. C) The right femoral artery was exposed, the aortic stent
delivery system was inserted into brachiocephalic artery, the bare stent frame was placed to the left of the brachiocephalic artery,
and the stent was released.
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Figure 3 Group C. A) CTA revealed Stanford type A dissection. B) DSA showed tear at the distal LSA. C) Stent graft implanted. D)
CTA 3 months postoperatively indicated the dissection is no longer present and thrombus formation inside the dissection cavity.
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the surgery. Up to the most recent follow-up or death, there
were 32 cases with complete thrombosis and 10 cases with
partial thrombosis inside the false lumen.
Type I endoleaks occurred in 10 patients (Table 2). The
endoleak associated with the intra-operative death has
been described above. In one case in which the LSA was
occluded intra-operatively, the endoleak was considered to
be caused by reflux of the LSA. An occluder was implanted
to occlude the ostium of LSA. In four cases, the endoleaksTable 2 Summary of complications by group.
Group A:
Entry Tear at
Ascending Aort
Mortality within 30-days postoperatively 1
Mortality after 30-days postoperatively 1
Type I endoleak 1
Cerebral infarction 2
Pseudo-aneurysm 1
Neck haematoma 0did not decrease after ballooning; however, they resolved
after aortic extending cuff placement. In the other four
patients, endoleaks were dramatically diminished after
balloon expansion. No further treatment was performed. In
group C, a secondary type II endoleak occurred 6 months
postoperatively. It was assumed to be caused by reflux of
the RVA, and no treatment was performed. During 2 years
of follow-up, no significant change has occurred.
During the follow-up period, there were a total of three
cases of cerebral infarction; thus the cerebral infarctiona
Group B:
Entry Tear at
Aortic Arch
Group C
Entry Tear at Descending
Aorta or Distal Aortic Arch
1 1
1 0
6 3
1 0
0 0
1 0
792 C. Ye et al.rate was 6.8% (3/44, one intra-operative death was not
counted). In group A, two patients who received endovas-
cular treatment through the LCCA experienced infarctions
at 3 weeks and 1 year postoperatively, respectively. In
group B, one patient experienced an infarction on post-
operative day 1. In all cases, studies of the revascularised
branches revealed patency.
There were only two complications other than those
previously described, and no patient experienced renal
failure, pulmonary failure, myocardial infarction, deep vein
thrombosis or paralysis. In addition, there were no cases of
distal malperfusion, cardiac effusion or aortic regurgita-
tion. In group A, one patient with DeBakey type I dissection
had an LSAeLCCAeRCCA bypass with artificial grafts and
stent implantation in a single-stage procedure. A pseudo-
aneurysm at the anastomotic site of the LSA and artificial
graft was found 8 months postoperatively and a right axil-
laryeright external iliac artery bypass with pseudo-
aneurysm resection was performed and the proximal ends
of LSA and the artificial graft were ligated. A neck hae-
matoma occurred in a patient in group B 3 weeks post-
operatively and resulted in airway compression. The
haematoma was evacuated and the patient recovered.
Complications are summarised in Table 2.
Discussion
We have reported the use of an endovascular approach to
treat 45 patients with Stanford type A ADs: the 30-day
postoperative mortality rate was 6.7% (3/45) and with
a mean follow-up of 35.5  5.4 months, total mortality rate
was 11.6% (5/43) and the cerebral infarction rate was 6.6%
(3/45). The mortality rate reported for our series is at the
low end of the reported surgical mortality of 7e30% for
Stanford type A dissections.18 Despite the utility of the
endovascular approach for Stanford type B dissections,19
experience of endovascular stent implantation for type A
dissections is still somewhat limited. In the current anal-
ysis, we grouped patients based on the location of the entry
tear.
Entry tear at the ascending aorta
In 2000, Dorros et al.20 reported the first DeBakey type I
case successfully treated with an endovascular technique.
In 2002, we reported the first case of a DeBakey type I
dissection treated with an endovascular technique in
China21 and have since treated an additional 10 cases. The
stents were implanted through the LCCA in two of the 10
cases described above. Because the early generation of the
device was rigid, it was difficult to deploy the guide sheath
through the aortic arch into the ascending aorta; thus
initially the LCCA was chosen to facilitate the release of the
stent. We first created a carotid shunt to build a LSAeLCCA
bypass to assure the blood supply to the brain, then the
LCCA was opened and the stent was inserted. In eight
cases, we implanted stent grafts through the RCFA into the
AO. Based on our experience, the RCFA path is suitable for
patients with a lesser curvature of the aortic arch.
Furthermore, the RCFA approach avoids blockage of
common carotid arteries, the necessity of carotid arterybypass and potentially the occurrence of cerebrovascular
events.
Entry tear at the aortic arch
To treat Stanford type A dissections with the entry tear
located at the aortic arch, protection of the supra-aortic
great vessels to guarantee the blood supply to the head and
neck after sealing the entry tear is necessary. In our
experience, the landing area for the stent was not usually
sufficient. In this situation, transposition of the aortic arch
great vessels can provide enough landing area for endo-
vascular stent implantation. Bergeron et al.22 reported
transposition of all of the large arch vessels in 15 cases and
partial vessel transposition in 10 cases prior to stent-graft
implantation, with a surgical success rate of 92%. In our
study, one patient with the entry tear at the aortic arch
died from sudden cardiac arrest when a balloon was
expanded to treat a type I endoleak. We hypothesise that
over expansion of balloon lead to rupture of aneurysm and
subsequent cardiac arrest; however, the patient’s family
did not agree to an autopsy, so the exact cause of death is
uncertain.
Entry tear located at the descending aorta or distal
aortic arch
Most surgeons use a hybrid technique to treat Stanford A
dissections with the entry tear located at the descending
aorta or distal aortic arch, which includes replacing the AO
and aortic arch (semi-arch or total arch) with artificial
vessels, and then stent implantation through the open aorta
to block the intimal tear. For patients in whom the LSA
needs to be closed, whether LSA revascularisation is
necessary or not depends on the blood supply in the RVA
and the left upper limb. Jazayeri et al.23 reported the
successful treatment of two Stanford type A dissections,
one with the tear at the descending aorta and the other at
the aortic arch. Both cases had ascending aorta replace-
ment, with additional half aortic arch replacement in one
case. In both cases, the stent graft was implanted inside
the artery to block the tear on the descending aorta and
aortic arch. Kato et al.24 reported 10 cases of Stanford type
A dissection successfully treated with stent-graft implan-
tation, and Uchida et al.25 reported a mortality rate of 4.6%
and 5-year survival of 92.8% in 65 cases of acute Stanford
type A dissection treated with aortic arch replacement plus
stent-graft implantation to block the tear at distal aorta.
If the intimal entry tear at the distal aortic arch or
proximal descending aorta is too close to the LSA, it may be
necessary to cover the LSA to achieve a sufficient landing
area for the stent, and it is debated whether revascular-
isation of the LSA is necessary. Based on our experience,
the decision should be made based on the blood supply in
the RVA.
Endoleaks
There were 10 type I endoleaks following stent implanta-
tion in our series (22.2%). All were treated with balloon
expansion, and the endoleak was decreased in four
Treatment of Stanford Type A Dissection 793patients. We perform balloon dilatation only in the landing
area of the stent graft in front of the entry tear, not for the
whole length of the stent graft. The purpose is to make the
stent adhere well to the blood vessel wall. The balloon
dilatation time is very short, only 2e3 s. The systolic blood
pressure is reduced to 90 mmHg during balloon dilatation to
prevent shifting of the stent graft. Balloon dilatation is
performed only once, and if the endoleak persists an aortic
extending cuff is used. Our selectivity in choosing cases in
which to do balloon dilatation is likely the reason no
retrograde dissections occurred (i.e., we did not do balloon
dilatation at the entry site tear or for the whole stent
graft).
In cases in which an endoleak is not decreased by
balloon expansion, reasons for the endoleak should be
investigated. If the edge of the stent was close to the entry
tear which was not completely sealed, an aortic extending
cuff can be implanted to seal the tear. If the endoleak is
caused by reflux from the sealed LSA, an occluder can be
placed to close the ostium of LSA.
In conclusion, endovascular stent-graft treatment is
a minimally invasive and effective method to treat Stanford
type A AD. When necessary, it can be combined with the
arch vessel bypass to obtain sufficient anchoring area for
lesions involving the aortic arch to assure blood supply to
the head and neck.
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